Comera Life Sciences Q2 EPS $(0.08) Up From $(1.14) YoY, Sales $315.06K Up From $146.73K YoY
Portfolio Pulse from Benzinga Newsdesk
Comera Life Sciences (NASDAQ:CMRA) reported Q2 losses of $(0.08) per share, a 92.98% increase YoY. The company also reported $315.06K in sales, a 114.72% increase YoY.
August 10, 2023 | 12:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Comera Life Sciences reported a significant decrease in losses and a substantial increase in sales YoY.
Comera Life Sciences reported a significant decrease in losses per share and a substantial increase in sales compared to the same period last year. This indicates a positive financial performance and could potentially lead to a positive reaction in the stock market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100